Compare XRX & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XRX | ATRC |
|---|---|---|
| Founded | 1906 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 416.3M | 2.5B |
| IPO Year | 2019 | 2005 |
| Metric | XRX | ATRC |
|---|---|---|
| Price | $3.15 | $53.35 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 10 |
| Target Price | $3.82 | ★ $53.33 |
| AVG Volume (30 Days) | ★ 2.1M | 1.1M |
| Earning Date | 10-29-2026 | 10-28-2026 |
| Dividend Yield | ★ 3.16% | N/A |
| EPS Growth | 23.26 | ★ 74.74 |
| EPS | N/A | ★ 0.18 |
| Revenue | $117,000,000.00 | ★ $201,630,000.00 |
| Revenue This Year | $8.24 | $13.41 |
| Revenue Next Year | N/A | $12.12 |
| P/E Ratio | ★ N/A | $320.69 |
| Revenue Growth | N/A | ★ 15.40 |
| 52 Week Low | $1.19 | $25.36 |
| 52 Week High | $3.94 | $61.70 |
| Indicator | XRX | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 46.13 | 57.66 |
| Support Level | $2.97 | $26.95 |
| Resistance Level | $3.68 | $61.70 |
| Average True Range (ATR) | 0.17 | 2.10 |
| MACD | -0.04 | -0.69 |
| Stochastic Oscillator | 8.04 | 21.63 |
Xerox Holdings Corp is a workplace technology company, building and integrating services-led, software-enabled, workplace solutions for enterprises large and small. It provide advance document technology, services, software, and integrated IT infrastructure solutions for a range of customers including small and mid-sized businesses, large enterprises, governments and graphic communications providers, and for partners who serve them. Xerox serves customers globally in North America, Europe, Latin America, Brazil, Asia Pacific (APAC), the Middle East, Africa, and India.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.